Bifidobacterium lactis MAK16B42L and Reduced Disease Activity Index in Colitis Model

• Effect of a Ropy Exopolysaccharide-Producing Bifidobacterium animalis subsp. lactis Strain Orally Administered on DSS-Induced Colitis Mice Model

  • 2016-06-09
  • RCT
  • Frontiers in Microbiology 7
  • • C. Hidalgo-Cantabrana
    • F. Algieri
    • A. Rodríguez‐Nogales
    • T. Vezza
    • P. Martínez-Camblor
    • A. Margolles
    • P. Ruas-Madiedo
    • J. Gálvez

  • PubMed: 27375589
  • DOI: 10.3389/fmicb.2016.00868

  9 Insights on

  • Reduced Disease Activity Index in Colitis Model

  • High evidence

  The disease activity index (DAI) of the animal group treated with the ropy strain was significantly lower than of the DAI of the placebo group at the end of the treatment.

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes